Takeda
The Chinese health authority has approved lanadelumab to prevent Hereditary Angioedema (HAE) attacks in persons of 12 years and older. It has also approved icatibant to treat acute HAE attacks in persons 2 years and older. One of the main aims of this study is to learn about the number of HAE attacks in 1 month in Chinese persons with HAE during their treatment with lanadelumab. The other main aim is to learn how much time is needed to resolve acute HAE attacks when treated with icatibant. Other aims of this study are to learn more about side effects of lanadelumab and icatibant treatment as well as to collect additional information on the treatment with lanadelumab, such as the dose and how often it needs to be given, reasons for stopping the treatment with lanadelumab and how long it was taken until stopping. Participants will be treated by their doctors according to routine medical practice. Only data already available in the medical records of the participants will be reviewed and collected during this study.
Hereditary Angioedema (HAE)
No intervention
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 130 participants |
Official Title : | The Real-World Effectiveness and Safety of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) for Hereditary Angioedema: An Observational Study in China |
Actual Study Start Date : | 2024-07-20 |
Estimated Primary Completion Date : | 2025-08-13 |
Estimated Study Completion Date : | 2025-08-13 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
The First Affiliated Hospital of Fujian Medical University
F U-axis, Fujan, China, 350005
RECRUITING
The First Affiliated Hospital ,Sun Yat-sen University
Guangzhou, Guangdong, China, 510080
RECRUITING
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510260
RECRUITING
Henan Provincial People's Hospital
Zhengzhou, Henan, China, 450003
RECRUITING
Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology
Wuhan, Hubei, China, 430030
RECRUITING
The First Hospital of China Medical University
Shenyang, Liaoning, China, 110001
RECRUITING
Qianfo Mountain Hospital, Shandong Province
Women, Shandong, China, 250014
RECRUITING
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai, China, 200011
RECRUITING
Shanxi Bethune hospital
Taiyuan, Shanxi, China, 030032
RECRUITING
The Second Affiliated hospital of Xian Jiaotong University
Xian, Shanxi, China, 710000
RECRUITING
West China Hospital of Sichuan University
Chengdu, Sichuan, China, 610041
RECRUITING
First Affiliated hospital of Kunming Medical University
Kunming, Yunnan, China, 650032
RECRUITING
The Second Affiliated hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009